Related Experiment Video
Updated: Mar 27, 2026

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
PTEN recruitment controls synaptic and cognitive function in Alzheimer's models.
Shira Knafo1,2,3, Cristina Sánchez-Puelles1, Ernest Palomer1
1Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
In Alzheimer's disease, amyloid-β peptide (Aβ) impairs synaptic function. Inhibiting PTEN, a key enzyme, restored normal cognition and synaptic plasticity in models, revealing a new therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Amyloid-β peptide (Aβ) dyshomeostasis is implicated in Alzheimer's disease (AD) pathogenesis, causing synaptic dysfunction and cognitive decline.
- Aβ disrupts synaptic plasticity, favoring long-term depression (LTD), a cellular mechanism underlying memory formation.
Purpose of the Study:
- To investigate the role of the lipid phosphatase PTEN in Aβ-induced synaptic malfunction.
- To identify the molecular mechanisms by which Aβ affects PTEN and synaptic function.
Main Methods:
- Utilized cellular and animal models of Alzheimer's disease.
- Employed PTEN inhibition and overexpression strategies.
- Investigated Aβ-induced PTEN recruitment to the postsynaptic compartment using a PTEN knock-in mouse model lacking the PDZ motif and cell-permeable interfering peptides.
Main Results:
- Inhibition of PTEN rescued synaptic function and cognition in AD models.
- Overexpression of PTEN induced synaptic depression mimicking Aβ effects.
- Aβ triggers PDZ-dependent postsynaptic recruitment of PTEN, a critical step in Aβ-induced synaptic toxicity and cognitive deficits.
Conclusions:
- PTEN plays a crucial role in mediating Aβ-induced synaptic depression and cognitive impairment in Alzheimer's disease.
- Targeting the Aβ-PTEN interaction offers a potential therapeutic strategy for Alzheimer's disease.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

